Sequences

Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

3,061 publications in 1,851 families match these filters.

  1. US 12269844-B22025-04-08

    Process for purifying semaglutide and liraglutide

    ScinoPharm Taiwan, Ltd.

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  2. GLUCAGON-LIKE PEPTIDE 1 AGONISTS

    CONSTRUCTIVE BIOLOGY LTD

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  3. JP 2025082834-A2025-05-29

    COMPOUNDS FOR THE TREATMENT OF DIABETES OR OBESITY

    Eli Lilly and Company

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  4. Method for preparing liraglutide with GLP-1 analogues

    HANKOOK KORUS PHARMACEUTICAL CO., LTD

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  5. AMYLIN ANALOGUES FOR REDUCING CONSUMPTION OF HIGH-FAT FOOD

    ZEALAND PHARMA AS

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  6. PETRELINTIDE FOR REDUCING WEIGHT WHILST PRESERVING LEAN MASS

    ZEALAND PHARMA AS

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  7. US 12338271-B22025-06-24

    Fusion protein including GIP and FGF21 and compositions thereof

    JIANGNAN UNIVERSITY

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  8. FERMENTATION PROCESS

    NOVO NORDISK AS

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  9. US 12350320-B22025-07-08

    Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and pharmaceutically acceptable salts of amylin analogs, and uses thereof

    i2O Therapeutics, Inc.

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  10. HIGH LEVEL PRODUCTION OF PEPTIDES AND PROTEINS

    SUN PHARMACEUTICAL IND LTD

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  11. HIGH LEVEL PRODUCTION OF GLP1 ANALOGUES

    SUN PHARMACEUTICAL IND LTD

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  12. EP 4619414-A12025-09-24

    VIRUS-LIKE PARTICLES WITH PROGRAMMABLE TROPISM AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS

    MASSACHUSETTS GEN HOSPITAL

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  13. EP 4619531-A12025-09-24

    SELF-REPLICATING RNA AND USES THEREOF

    UNIV BOSTON

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  14. PROCESS FOR THE PREPARATION OF TETRAPEPTIDE FRAGMENT OF LIRAGLUTIDE

    Fresenius Kabi Oncology Limited

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  15. METHODS AND USES FOR TREATING NAUSEA AND EMESIS

    Eli Lilly and Company

    Query Match 98.1%Identity 96.8%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  16. JP 2025538398-A2025-11-28

    VIRUS-LIKE PARTICLES WITH PROGRAMMABLE TROPISM AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS

    THE GENERAL HOSPITAL CORPORATION

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  17. PEPTIDE TYROSINE-TYROSINE ANALOG AND USE THEREOF

    THE UNITED BIO-TECHNOLOGY (HENGQIN) CO., LTD

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  18. JP 2025179058-A2025-12-09

    BARCODED POLYPEPTIDES AND COMPOSITIONS THEREOF, AND METHODS FOR MAKING AND USING THE SAME

    AMUNIX PHARMACEUTICALS, INC

    Query Match 98.1%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||||| |
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGKG 31
    

    30 of 31 identical, no gaps.

  19. COMPOSITIONS AND METHODS FOR IMPROVING INSULIN SENSITIVITY

    ELI LILLY AND COMPANY

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  20. Pharmaceutical composition comprising peptide derivatives and albumin

    SNBioScience Inc

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  21. US 12551566-B22026-02-17

    Dual amylin and calcitonin receptor agonists and uses thereof

    Eli Lilly and Company et al

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  22. EP 4696708-A12026-02-18

    PEPTIDE TYROSINE-TYROSINE ANALOG AND USE THEREOF

    THE UNITED BIO TECH HENGQIN CO LTD

    Query Match 98.1%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||||||| |||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
    

    30 of 31 identical, no gaps.

  23. EP 0955314-A21999-11-10

    Peptide analogues of glucagon-like-peptide-1 (7-37), their preparation and pharmaceutical compositions

    ADIR (FR)

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || ||||||||||||||||||||||||||||
    Hit    1 HAKGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  24. METHOD FOR ADMINISTERING INSULINOTROPIC PEPTIDES

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HVEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  25. JP 2002523466-A2002-07-30

    Method of administration of insulin tropistic peptide

    ELI LILLY AND CO

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HVEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  26. JP 2002533072-A2002-10-08

    Recombinant synthesis of beta-lipotropin and other peptides

    ELI LILLY AND CO

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 97 to 127. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              | |||||||||||||||||||||||||||||
    Hit    97 HVEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 127
    

    30 of 31 identical, no gaps.

  27. US 6620910-A2003-09-16

    Peptide compounds analogues of the glucagon-like peptide-1 (7-37)

    Les Laboratoires Servier

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || ||||||||||||||||||||||||||||
    Hit    1 HAKGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  28. US 6720407-A2004-04-13

    Method for administering insulinotropic peptides

    Eli Lilly and Company

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HVEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  29. EP 1666054-A12006-06-07

    No title supplied

    Eli Lilly & Company (US)

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HVEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  30. WO 2007124461-A2007-11-01

    Glp-1 compounds

    Amgen, Inc (US)

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  31. Compositions and methods for producing bioactive fusion proteins

    Amgen, Inc (US)

    Query Match 97.5%Identity 96.8%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 60/931344.

  32. JP 2009534423-A2009-09-24

    GLP-1 Compounds

    Amgen Inc

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  33. Drug fusions and conjugates

    Glaxo Group Limited (GB)

    Query Match 97.5%Identity 96.8%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  34. Methods for selecting protease resistant polypeptides

    Glaxo Group Limited (GB)

    Query Match 97.5%Identity 96.8%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. Fgfr1c antibody combinations

    GLAXO GROUP LTD

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  36. DRUG FUSIONS AND CONJUGATES WITH EXTENDED HALF LIFE

    GLAXO GROUP LTD

    Query Match 97.5%Identity 96.8%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  37. EP 2307038-A22011-04-13

    THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

    UNIV DUKE

    Query Match 97.5%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  38. JP 2011517561-A2011-06-16

    Drug fusions and Conjugates

    Glaxo Group Limited

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  39. JP 2011526303-A2011-10-06

    THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

    DUKE UNIVERSITY

    Query Match 97.5%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 61/076221.

  40. US 8178495-B22012-05-15

    Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide

    Duke University

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  41. JP 2012116864-A2012-06-21

    GLP-1 Compounds

    Amgen Inc

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  42. JP 2012513981-A2012-06-21

    GLP-I analogs and uses thereof.

    Panacea Biotec Ltd

    Query Match 97.5%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  43. MODIFIED PIG ISLETS FOR DIABETES TREATMENT

    UNIV LOUVAIN

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    7 HXEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    30 of 31 identical, no gaps.

  44. JP 2012521197-A2012-09-13

    CARRIER IMMUNOGLOBULINS AND USES THEREOF

    AMGEN INC

    Query Match 97.5%Identity 96.8%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 61/210594.

  45. JP 2012521971-A2012-09-20

    Drug fusions and conjugates

    GLAXO GROUP LIMITED

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  46. COMPOSITIONS COMPRISING FUSION PROTEINS OR CONJUGATES WITH AN IMPROVED HALF -LIFE

    GLAXO GROUP LTD

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  47. CCK COMPOSITIONS

    GLAXO GROUP LTD

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  48. CARRIER IMMUNOGLOBULINS AND USES THEREOF

    AMGEN Inc

    Query Match 97.5%Identity 96.8%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  49. JP 2013541947-A2013-11-21

    CARRIER IMMUNOGLOBULINS AND USES THEREOF

    AMGEN INC

    Query Match 97.5%Identity 96.8%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             | |||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 61/385460.

  50. US 8614182-B22013-12-24

    GLP-1 analogues and their pharmaceutical salts and uses

    Jiangsu Hansoh Pharmaceuticals Co., Ltd.

    Query Match 97.5%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||||||| |||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIVWLVKGRG 31
    

    30 of 31 identical, no gaps.